Gunnar Juliusson
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 114
- Hematology top 0.1%
- Acute Myeloid Leukemia Research 39
- Multiple Myeloma Research and Treatments 16
- Hematopoietic Stem Cell Transplantation 14
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 60
- Immunology top 1%
- Immunodeficiency and Autoimmune Disorders 45
- Oncology top 1%
- Viral-associated cancers and disorders 15
-
- Acute Lymphoblastic Leukemia research 45
Gunnar Juliusson
186 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Genetics 4.4k
- Hematology 3.3k
- Pathology and Forensic Medicine 2.8k
- Immunology 2.3k
- Oncology 2.4k
Countries citing papers authored by Gunnar Juliusson
This map shows the geographic impact of Gunnar Juliusson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Juliusson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Juliusson more than expected).
Fields of papers citing papers by Gunnar Juliusson
This network shows the impact of papers produced by Gunnar Juliusson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Juliusson. The network helps show where Gunnar Juliusson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gunnar Juliusson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2019 | 22 | |
| 5 | 2016 | 147 | |
| 6 | 2015 | 1 | |
| 7 | 2014 | 13 | |
| 8 | 2013 | 2 | |
| 9 | 2012 | 203 | |
| 10 | 2012 | 84 | |
| 11 | Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registrybreakdown → | 2008 | 683 |
| 12 | 2004 | 32 | |
| 13 | 2003 | 37 | |
| 14 | Thalidomide frequently induces good partial remission and best response ever in patients with advanced myeloma and prior high dose melphalan and autotransplant. | 1999 | 6 |
| 15 | 1998 | 9 | |
| 16 | 1997 | 38 | |
| 17 | Chromosome 13q14 deletions in lymphoid malignancies | 1996 | 1 |
| 18 | 1996 | 24 | |
| 19 | 1991 | 11 | |
| 20 | 1985 | 15 |
About Gunnar Juliusson
Gunnar Juliusson is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 189 papers that have together received 9.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (114 papers), Lymphoma Diagnosis and Treatment (60 papers), Immunodeficiency and Autoimmune Disorders (45 papers), Acute Lymphoblastic Leukemia research (45 papers), Acute Myeloid Leukemia Research (39 papers), Multiple Myeloma Research and Treatments (16 papers), Viral-associated cancers and disorders (15 papers) and Hematopoietic Stem Cell Transplantation (14 papers). The work is most often cited by research in Genetics (4.4k citations), Hematology (3.3k citations) and Pathology and Forensic Medicine (2.8k citations). Gunnar Juliusson has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Jan Liliemark, Gösta Gahrton, Martin Höglund, Lars Möllgård, Ulf Tidefelt, Anders Wåhlin, Dick Stockelberg, Åsa Rangert Derolf, Freidoun Albertioni and Petar Antunović. Their work appears in journals such as Blood, British Journal of Haematology, European Journal Of Haematology, Journal of Clinical Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.